Skip to content
Latest News
Alphawave IP (AWE) Shares Surge After 140% Revenue Growth

Shares of Alphawave IP (LON: AWE) are rallying after the company reported its interim results for the six months ended June 30.  The wired connectivity solutions firm rep

Sam Boughedda
Union Jack Oil (UJO) Shares Gain On “Highly Encouraging” Update

Union Jack Oil (LON: UJO) on Tuesday revealed a "highly encouraging" update in respect of ongoing operations at the Wressle hydrocarbon development.  The Wressle hydrocar

Sam Boughedda
United Oil & Gas (UOG) Shares Rise After Encountering Primary Reservoir Targets 

On Tuesday, United Oil & Gas (LON: UOG) said that its ASX-1X exploration well encountered at least 10m net pay in several oil-bearing reservoirs, resulting in its share price rising.

Sam Boughedda
Botswana Diamonds (BOD) Shares Jump After 9 Hole Drilling Programme Complete

Shares of Botswana Diamonds (LON: BOD) are gaining on Tuesday morning after the company completed the nine-hole drilling programme on the Thorny River property in South Africa.

Sam Boughedda
Innate Pharma (IPHA) Stock Soars on Positive Results From AstraZeneca’s Joint Study

Innate Pharma SA (NASDAQ: IPHA) stock soared 108% higher after AstraZeneca announced a joint clinical study’s positive phase 2 clinical trial data. AstraZeneca revealed that the study, which combined Innate Pharma’s monalizumab and AZN’s durvaluma

Simon Mugo
Caerus Mineral (CMRS) Shares Edged 4.35% Higher on Copper and Gold Discoveries

Shares of Caerus Mineral Resources PLC (LON: CMRS) on positive updates regarding its dump evaluation program of its Kalavasos Project in Cyprus. The mining and mineral exploration company revealed that initial assay results had shown significant c

Simon Mugo
Myhealthchecked (MHC) Shares Rallied 16.7% on Reaction to New UK Govt Travel Rules

Myhealthchecked PLC (LON: MHC) shares rallied 16.74% after re-issuing a statement regarding the British government’s revised testing regimes for travellers arriving in the country from specific countries. The British government is set to lift the

Simon Mugo
Haydale Graphene (HAYD) Shares Just Crashed 18.8% to Key Support. Should You Buy?

Shares of Haydale Graphene Industries PLC (LON: HAYD) crashed 18.8% after announcing a discounted share placement to raise £4.5 million via an accelerated bookbuild. Investors were not happy to see that the shares sold during the placement were pr

Simon Mugo
Globalstar (GSAT) Stock Is Down 31.9% Over the Past Week. Will It Keep Falling?

Globalstar, Inc. (NYSEAMERICAN: GSAT) stock price is down 31.9% over the past week ever since Apple Inc announced that the iPhone 13 would not support satellite communication as many reviewers and investors were expecting. Most of the company’s sh

Simon Mugo
Edesa Biotech (EDSA) Stock Was Up 70% After Its COVID-19 Drug Reduced the Patient Mortality Rate

Edesa Biotech Inc (NASDAQ: EDSA) stock was up 70% premarket after releasing excellent results from its phase 2 clinical trial of its monoclonal antibody candidate EB05 as a single-dose treatment for hospitalized COVID-19 patients. The study was pr

Simon Mugo
British Airways Owner IAG Shares Rally on US Travel Reports

Shares of International Consolidated Airlines Group (LON: IAG) are rallying in Monday afternoon trading after it was reported by the Financial Times that the US will relax travel restrictions for UK and EU visitors

Sam Boughedda
GameStop To Hire 500 Employees in Florida – GME Shares Down Premarket

On Monday, GameStop (NYSE: GME) announced that it plans to hire up to 500 employees at its newly-leased customer service center in Pembroke Pines, Florida. The new facili

Sam Boughedda
Verastem Oncology (VSTM) Stock Rallies On Collaboration Agreement with Amgen

Shares of Verastem (NASDAQ: VSTM) are rallying premarket on Monday after it announced a clinical collaboration agreement with Amgen to evaluate the combination of VS-6766 with Amgen’s KRAS G12C inhibitor LUMAKRASTM

Sam Boughedda
Zivo Bioscience (ZIVO) Stock Soared 199.3% Amid Premarket Buying Frenzy

Shares of Zivo Bioscience Inc (NASDAQ: ZIVO) inexplicably soared 199.3% amid a flood of buying pressure despite not making an official announcement by the time of writing. Despite the lack of official news from the company, it seems that investors

Simon Mugo
Synlogic (SYBX) Stock Surges On Positive Phenylketonuria Treatment Data

Synlogic (Nasdaq: SYBX) shares are rallying premarket after the company reported positive data from clinical studies evaluating SYNB1618 and SYNB1934, investigational Synthetic Biotic medicines for the treatment of phenylketonuria (PKU). In an int

Sam Boughedda
Open Orphan Shares Rise – hVIVO Wins £5.7m Human Study Contract, Revenue Surges

Open Orphan (LON: ORPH) shares are rallying premarket after announcing that its subsidiary, hVIVO, has signed a new £5.7m contract with a specialist biotechnology company. The contract is with a firm developing therapeutics for respiratory viral i

Sam Boughedda
UK Oil & Gas (UKOG) Shares Rise After Completing Horse Hill Production Facilities Upgrade

Shares of UK Oil & Gas (LON: UKOG) are rising on Monday following news that it has completed a planned two-week production facility upgrade at its 85.63% owned Horse Hill oil field. Upgrade works at the oil field included modifications to prep

Sam Boughedda
Alba Mineral Resources Shares Rally After Obtaining Additional Mineral Exploration Licence

Shares of AIM-quoted Alba Mineral Resources (LON: ALBA) are rallying on Monday on news that it has obtained an additional exclusive mineral exploration licence. The addit

Sam Boughedda
Asana Stock Is Up 53.7% Over The Past Month. Is a Pullback Long Overdue?

Asana Inc (NYSE: ASAN) stock has risen 53.7% over the past month as company insiders led by its CEO Dustin Moskovitz continue accumulating shares in the firm. According to a credible report, Dustin Moskovitz bought an additional 750,000 shares of

Simon Mugo
Corvus Pharma (CRVS) Stock Soared 82.3% Driven by Positive Investor Sentiment

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) stock soared 82.3% despite a lack of fundamental releases from the company today. However, the markets may be reacting to the clinical-stage company’s participation in the H.C. Wainwright Annual Global Inv

Simon Mugo